SMIT1 haploinsufficiency causes brain inositol deficiency without affecting lithium-sensitive behavior (Q28505983)

24 January 2017

title

SMIT1 haploinsufficiency causes brain inositol deficiency without affecting lithium-sensitive behavior (English)

1 reference

Solute carrier family 5 (inositol transporters), member 3

24 January 2017

0 references

0 references

1 reference

GOA release 2020-03-11

9

Gerard T. Berry

1 reference

24 January 2017

6

R. H. Belmaker

1 reference

24 January 2017

5

Galila Agam

1 reference

24 January 2017

Alona Shaldubina

1

1 reference

24 January 2017

Roy A. Johanson

2

1 reference

24 January 2017

W. Timothy O'Brien

3

1 reference

24 January 2017

Roberto Buccafusca

4

1 reference

24 January 2017

Peter S. Klein

7

1 reference

24 January 2017

Yuly Bersudsky

8

1 reference

24 January 2017

publication date

1 August 2006

1 reference

Molecular Genetics and Metabolism

24 January 2017

published in

1 reference

24 January 2017

volume

88

1 reference

24 January 2017

issue

4

1 reference

24 January 2017

page(s)

384–388

1 reference

An expanded view of inositol signaling

24 January 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.03.007

A molecular mechanism for the effect of lithium on development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.03.007

Lithium and valproic acid: parallels and contrasts in diverse signaling contexts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.03.007

Neural and developmental actions of lithium: a unifying hypothesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.03.007

Reduced Brain Inositol in Lithium-treated Rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.03.007

Chronic lithium and sodium valproate both decrease the concentration of myo-inositol and increase the concentration of inositol monophosphates in rat brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.03.007

A common mechanism of action for three mood-stabilizing drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.03.007

Ziskind-Somerfeld Research Award 1993. Biochemical, behavioral, and clinical studies of the role of inositol in lithium treatment and depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.03.007

Toward a crystal-clear view of lithium's site of action.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.03.007

Lithium and brain signal transduction systems

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.03.007

Loss of murine Na+/myo-inositol cotransporter leads to brain myo-inositol depletion and central apnea

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.03.007

Phosphoinositide deficiency due to inositol depletion is not a mechanism of lithium action in brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.03.007

Behavioral evidence for the existence of two pools of cellular inositol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.03.007

Lithium inhibits glycogen synthase kinase-3 activity and mimics wingless signalling in intact cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.03.007

Lithium inhibits Alzheimer's disease-like tau protein phosphorylation in neurons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.03.007

Glycogen synthase kinase-3beta haploinsufficiency mimics the behavioral and molecular effects of lithium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.03.007

Lithium antagonizes dopamine-dependent behaviors mediated by an AKT/glycogen synthase kinase 3 signaling cascade

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.03.007

AR-A014418, a selective GSK-3 inhibitor, produces antidepressant-like effects in the forced swim test

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.03.007

Long-term treatment with novel glycogen synthase kinase-3 inhibitor improves glucose homeostasis in ob/ob mice: molecular characterization in liver and muscle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.03.007

How versatile are inositol phosphate kinases?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.03.007

Effect of the IMPase inhibitor L690,330 on sea urchin development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.03.007

Glycogen synthase kinase-3 regulates mouse oocyte homologue segregation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.03.007

High-dose peripheral inositol raises brain inositol levels and reverses behavioral effects of inositol depletion by lithium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.03.007

Activation of the Wnt signaling pathway: a molecular mechanism for lithium action

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.03.007

10.1016/J.YMGME.2006.03.007

7 January 2021

Identifiers

DOI

0 references

1 reference